XML 33 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income (loss) $ (6,917.9) $ 2,748.8 $ 527.8
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 433.9 635.6 437.2
Impairment of goodwill, intangibles and other assets 9,789.5 85.0  
Net gain from sale of businesses (832.9) (713.0) (161.1)
Loss on extinguishment of debt (6.3) (1.9) 47.6
Deferred income taxes (1,597.9) (1,781.8) 33.4
Stock-based compensation expense 75.7 70.9 63.9
Pension settlement charge (gain)   (2.4) 2.7
Other, net 4.2 11.0 44.7
Changes in operating assets and liabilities, excluding the effects of acquisitions and divestitures:      
Accounts receivable 161.7 288.7 (324.5)
Inventories 125.7 (350.4) 784.6
Accounts payable (309.3) 211.0 282.0
Accrued liabilities and other (246.4) (235.3) 102.1
Net cash provided by operating activities 680.0 966.2 1,840.4
Cash flows from investing activities:      
Proceeds from sale of divested businesses 5,133.3 2,106.9 227.2
Acquisitions and acquisition-related activity   (634.3) (8,635.2)
Capital expenditures (384.4) (406.2) (441.4)
Other investing activities 58.5 12.1 24.6
Net cash provided by (used in) investing activities 4,807.4 1,078.5 (8,824.8)
Cash flows from financing activities:      
Net short-term debt (903.5) 111.8 (641.4)
Loss on extinguishment of debt (10.4) (34.2)  
Proceeds from issuance of debt, net of debt issuance costs     9,414.6
Payments on long-term debt (2,579.9) (1,512.2) (1,100.0)
Repurchase and retirement of shares of common stock (1,507.3) (152.4)  
Cash dividends (434.6) (428.6) (328.6)
Payments to dissenting shareholders   (161.6)  
Option proceeds net of repurchase of restricted shares for vesting (18.8) (18.6) (16.1)
Net cash provided by (used in) financing activities (5,454.5) (2,195.8) 7,328.5
Exchange rate effect on cash and cash equivalents (22.9) 49.3 (31.4)
Increase (decrease) in cash and cash equivalents 10.0 (101.8) 312.7
Cash and cash equivalents at beginning of period 485.7 587.5 274.8
Cash and cash equivalents at end of period 495.7 485.7 587.5
Supplemental disclosures:      
Net cash provided by discontinued operating activities 155.9 131.8 172.1
Net cash provided by (used in) discontinued investing activities 4,983.9 (137.6) (162.1)
Capital expenditures for discontinued operations (155.4) (140.0) (149.3)
Common stock issued for Jarden Acquisition     9,480.3
Debt assumed, at fair value, in the Jarden Acquisition     1,198.7
Cash paid for income taxes, net of refunds 292.0 261.8 189.2
Cash paid for interest $ 457.6 $ 459.4 $ 316.0